High-Throughput Detection of Degraded Polysorbate in Biological Formulations with FMM

Significance of the Topic

Polysorbates are ubiquitous excipients in parenteral biologics but degrade over time into free fatty acid particles that compromise product quality and safety. Detecting these low-abundance particles in complex protein formulations is critical for regulatory compliance and therapeutic efficacy.

Objectives and Study Overview

This study presents the Aura polysorbate degradation assay, a high-throughput method employing fluorescence membrane microscopy to quantify free fatty acid particles resulting from polysorbate 20 degradation. The goal is to achieve sensitive and specific detection within protein-rich matrices.

Methodology and Instrumentation

Standard solutions of polysorbate 20 with or without human IgG and mixtures of lauric, myristic, and palmitic acids were prepared in acetate buffer. Free fatty acid particles were stained with BODIPY FL C16. The assay workflow involved background imaging, brightfield particle counting, fluorescent labeling, and dual-mode imaging using the Aura PTx system.

Instrumentation

The Aura PTx and Aura+ systems integrate backgrounded membrane imaging and fluorescence membrane microscopy. FL2 channel (excitation 482/35 nm, emission 524/24 nm) detects BODIPY FL C16–stained fatty acid particles. Optional FL1 channel (excitation 440/40 nm, emission 500/40 nm) supports concurrent protein aggregate identification.

Main Findings and Discussion

Morphological analysis revealed distinct shapes for lauric, myristic, and palmitic acid particles under brightfield. BODIPY FL C16 selectively stained fatty acid particles, yielding a staining efficiency of 73% in positive controls versus 6% background for protein aggregates. Fluorescence versus size plots confirmed strong correlation between particle size and signal intensity. The assay achieved a limit of detection of 9.38 micromolar lauric acid and limit of quantitation of 18.75 micromolar in the presence of human IgG.

Benefits and Practical Applications

The assay requires only 5 microliters of sample per well, analyzes 96 samples in a few hours, and provides visual verification of particle identity. It outperforms traditional solution-phase assays in sensitivity and throughput, making it suitable for formulation development and quality control.

Future Trends and Potential Applications

Future developments may include integration of multiplexed labeling for simultaneous detection of multiple excipient degradation products and aggregates, automation for in-process monitoring, and adaptation to other excipients and biopharmaceutical modalities.

Conclusion

The Aura polysorbate degradation assay offers a rapid, sensitive, and specific approach for detecting free fatty acid particles in biologic formulations, enhancing stability assessment and regulatory compliance across the biopharmaceutical industry.

Reference

1. Vaclaw C et al. Impact of Polysorbate 80 Grade on the Interfacial Properties and Interfacial Stress Induced Subvisible Particle Formation in Monoclonal Antibodies. J Pharm Sci. 2020;110(2):746–759.
2. Dwivedi M et al. Acidic and Alkaline Hydrolysis of Polysorbates Under Aqueous Conditions. Eur J Pharm Sci. 2020;144:105211.
3. Doshi N et al. Understanding Particle Formation: Solubility of Free Fatty Acids as Polysorbate 20 Degradation Byproducts in Therapeutic Monoclonal Antibody Formulations. Mol Pharm. 2015;12(11):3792–3804.
4. Glücklich N et al. An In-Depth Examination of Fatty Acid Solubility Limits in Biotherapeutic Protein Formulations Containing Polysorbate 20 and Polysorbate 80. Int J Pharm. 2020;591:119934.
5. Saggu M et al. Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight Into Polysorbate 20 Degradation Pathway. Pharm Res. 2015;32(9):2877–2888.
6. Doshi N et al. Improving Prediction of Free Fatty Acid Particle Formation in Biopharmaceutical Drug Products: Incorporating Ester Distribution during Polysorbate 20 Degradation. Mol Pharm. 2020;17(11):4354–4363.
7. Doshi N et al. Evaluation of Super Refined Polysorbate 20 With Respect to Polysorbate Degradation, Particle Formation and Protein Stability. J Pharm Sci. 2020;109(10):2986–2995.
8. Martos A et al. Novel High-Throughput Assay for Polysorbate Quantification in Biopharmaceutical Products by Using the Fluorescent Dye DiI. J Pharm Sci. 2020;109:646.